Skip to main content
Livermore
Livermore
ZHEN

Neuberger Berman Group LLC

SEC CIK
0001465109
Latest filing
Aug 13, 2026

BMRN holding history

Biomarin Pharmaceutical Inc in every 13F filed by Neuberger Berman Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BMRN overviewAll 13F holders of BMRNFull Q2 2026 holdings

Shares (Q2 2026)
16,196
Value
$926.7K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of BMRN by Neuberger Berman Group LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202616,196$926.7K<0.1%−21,273−56.8%ReducedHolders
Q1 202637,469$2.12M<0.1%+352+0.9%AddedHolders
Q4 202537,117$2.21M<0.1%+7,345+24.7%AddedHolders
Q3 202529,772$1.61M<0.1%−1,985−6.3%ReducedHolders
Q2 202531,757$1.75M<0.1%−64,410−67.0%ReducedHolders
Q1 202596,167$6.80M<0.1%+2,415+2.6%AddedHolders
Q4 202493,752$6.16M<0.1%−803,827−89.6%ReducedHolders
Q3 2024897,579$63.1M<0.1%−196,614−18.0%ReducedHolders
Q2 20241,094,193$90.1M0.1%+628,463+134.9%AddedHolders
Q1 2024465,730$40.7M<0.1%+117,008+33.6%AddedHolders
Q4 2023348,722$33.6M<0.1%+108,094+44.9%AddedHolders
Q3 2023240,628$21.3M<0.1%+40,032+20.0%AddedHolders
Q2 2023200,596$17.4M<0.1%+46,549+30.2%AddedHolders
Q1 2023154,047$15.0M<0.1%−14,975−8.9%ReducedHolders
Q4 2022169,022$17.5M<0.1%+2,185+1.3%AddedHolders
Q3 2022166,837$14.1M<0.1%+139,356+507.1%AddedHolders
Q2 202227,481$2.28M<0.1%−242−0.9%ReducedHolders
Q1 202227,723$2.14M<0.1%−4,964−15.2%ReducedHolders
Q4 202132,687$2.68M<0.1%+5,442+20.0%AddedHolders
Q3 202127,245$1.96M<0.1%−5,386−16.5%ReducedHolders
Q2 202132,631$2.58M<0.1%−4,570−12.3%ReducedHolders
Q1 202137,201$2.74M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.